EPS for Obalon Therapeutics, Inc. (OBLN) Expected At $-0.54 on May, 9

April 17, 2018 - By Mark Mitchell

Obalon Therapeutics, Inc. (NASDAQ:OBLN)’s earnings release is anticipated by WallStreet on May, 9, Faxor reports. Analysts predict 14.89 % diference or $-0.54 from the $-0.47 EPS from 2017. Last quarter $-0.60 earnings per share was reported. Analysts forecasts -10.00 % EPS growth this quarter. Its shares touched $3.27 on during the last trading session after 4.66% change.Obalon Therapeutics, Inc. has volume of 40,399 shares. Since April 17, 2017 OBLN has 0.00% and is . The stock underperformed the S&P500 by 11.55%.

Obalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss.The company has $57.23 million market cap. It offers the Obalon balloon system designed to provide weight loss in obese patients.Currently it has negative earnings.

Obalon Therapeutics, Inc. (NASDAQ:OBLN) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.